Cargando…

Preparation, Characterization, and Preliminary Imaging Study of [(188)Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis

BACKGROUND: Bone is a common site of metastasis from a malignant tumor. Several radiopharmaceuticals are available to relieve bone pain in patients with cancer. However, every radiopharmaceutical has its own disadvantages, and there is still a need to investigate easily accessible and high bone affi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Tingting, Wang, Yingwei, Chen, Zan, Liu, Hanxiang, Yang, Songsong, Liu, Guangfu, Zhao, Yan, Fu, Wenhui, Liu, Lin, Xiang, Ke, Peng, Dengsai, Chen, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896928/ https://www.ncbi.nlm.nih.gov/pubmed/35280705 http://dx.doi.org/10.1155/2022/7684076

Ejemplares similares

(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
por: Boschi, Alessandra, et al.
Publicado: (2017)

Preparation, biological characterization and preliminary human imaging studies of (68)Ga-DOTA-IBA
por: Wang, Yingwei, et al.
Publicado: (2022)

(188)Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates
por: Savio, Eduardo, et al.
Publicado: (2004)

Radiation Dose to the Occupational Worker during the Synthesis of (188)Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department
por: Thakral, Parul, et al.
Publicado: (2018)

(68)Ga and (188)Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies
por: Verger, Elise, et al.
Publicado: (2016)

Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry
por: Kleynhans, Janke, et al.
Publicado: (2023)

Preparation and biodistribution of (188)Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles ((188)Re-folate-CDDP/HSA MNPs) in vivo
por: Tang, Qiu-Sha, et al.
Publicado: (2011)

External beam radiotherapy synergizes (188)Re-liposome against human esophageal cancer xenograft and modulates (188)Re-liposome pharmacokinetics
por: Chang, Chih-Hsien, et al.
Publicado: (2015)

Rhenium-188 Production in Hospitals, by W-188/Re-188 Generator, for Easy Use in Radionuclide Therapy
por: Argyrou, Maria, et al.
Publicado: (2013)

Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021)

Intratumoral Injection of (188)Re labeled Cationic Polyethylenimine Conjugates: A Preliminary Report
por: Kim, Eun-Mi, et al.
Publicado: (2004)

Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma
por: Shih, Ying-Hsia, et al.
Publicado: (2014)

Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice
por: Guo, Rui, et al.
Publicado: (2014)

[(68)Ga]/[(188)Re] Complexed [CDTMP] Trans-1,2-Cyclohexyldinitrilotetraphosphonic Acid As a Theranostic Agent for Skeletal Metastases
por: Jaswal, Ambika P., et al.
Publicado: (2017)

PSMA-GCK01: A Generator-Based (99m)Tc/(188)Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
por: Cardinale, Jens, et al.
Publicado: (2023)

(188)Re-HEDP therapy in the therapy of painful bone metastases
por: Liepe, Knut
Publicado: (2018)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
por: Fani, Melpomeni, et al.
Publicado: (2017)

Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy
por: Barca, Cristina, et al.
Publicado: (2021)

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
por: Lepareur, Nicolas, et al.
Publicado: (2019)

Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer
por: Xiao, Jie, et al.
Publicado: (2016)

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023)

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology
por: Rahmim, Arman, et al.
Publicado: (2022)

AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications
por: Fersing, Cyril, et al.
Publicado: (2022)

Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals
por: Carter, Korey P., et al.
Publicado: (2020)

Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016)

RADIOACTIVE CEMENT OF PMMA AND HAP-Sm-153, Ho-166, OR RE-188 FOR BONE METASTASIS TREATMENT
por: Montaño, Carlos Julio, et al.
Publicado: (2019)

Gold Nanorods as Radiopharmaceutical Carriers: Preparation and Preliminary Radiobiological In Vitro Tests
por: Binelli, Ludovica, et al.
Publicado: (2023)

A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors
por: Wang, Shyh-Jen, et al.
Publicado: (2019)

Preparation and Properties of New Co-Crystals of Ibandronate with Gluco- or Galactopyranoside Derivatives †
por: Oktabec, Zbynek, et al.
Publicado: (2010)

Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples
por: Kolenc Peitl, Petra, et al.
Publicado: (2019)

Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics
por: Mkhatshwa, Marcus, et al.
Publicado: (2021)

The neutron capture cross sections of 186;187;188 Os and their application to Re/Os cosmochronometer
por: Fujii, Kaori
Publicado: (2009)

(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside
por: Lepareur, Nicolas, et al.
Publicado: (2012)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
por: Holik, Holis Abdul, et al.
Publicado: (2022)

(188)Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
por: Chang, Chia-Ming, et al.
Publicado: (2017)

High dose brachytherapy with non sealed (188)Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results.
por: Castellucci, Paolo, et al.
Publicado: (2020)

Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with (188)Re
por: De La Vega, José Carlos, et al.
Publicado: (2019)

Evaluation of a Proposed Biodegradable (188)Re Source for Brachytherapy Application: A Review of Dosimetric Parameters
por: Khorshidi, Abdollah, et al.
Publicado: (2015)

Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of (188)Re radionuclide for cancer therapy
por: Petriev, V. M., et al.
Publicado: (2019)

Biodistribution and pharmacokinetics of (188)Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice
por: Tsai, Chia-Che, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eh05par359e99p9bov620t5ls9